Afibrinogenemia
|
0.530 |
GeneticVariation
|
disease |
BEFREE |
This is the first report of a mutation in the fibrinogen gamma-chain gene causing afibrinogenemia and indicates that, in addition to the Aalpha and Bbeta-chain genes, the gamma-chain gene must also be considered in mutation screening for afibrinogenemia.
|
11001902 |
2000 |
Afibrinogenemia
|
0.530 |
Biomarker
|
disease |
MGD |
A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.
|
10980108 |
2000 |
Dysfibrinogenemia
|
0.060 |
Biomarker
|
disease |
BEFREE |
It is concluded that the residue gamma-Asp(330) is essential for the normal functioning of the polymerization site a on the fibrinogen gamma-chain.
|
11071644 |
2000 |
Congenital hypofibrinogenemia
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes.
|
11354637 |
2001 |
Congenital hypofibrinogenemia
|
0.740 |
GermlineCausalMutation
|
disease |
ORPHANET |
Fibrinogen gene mutations accounting for congenital afibrinogenemia.
|
11460507 |
2001 |
Afibrinogenemia
|
0.530 |
Biomarker
|
disease |
BEFREE |
Here, we report 13 further unrelated patients with mutations in FGA, confirming the relative importance of this gene compared with FGG and FGB in the molecular aetiology of afibrinogenemia.
|
11354637 |
2001 |
Inflammation
|
0.200 |
Therapeutic
|
phenotype |
RGD |
The responses of rat liver glucocorticoid receptors and genes for tyrosine aminotransferase, alpha-2-macroglobulin and gamma-fibrinogen to adrenalectomy-, dexamethasone- and inflammation-induced changes in the levels of glucocorticoids and proinflammatory cytokines.
|
11490095 |
2001 |
Afibrinogenemia
|
0.530 |
Biomarker
|
disease |
MGD |
Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse.
|
11891199 |
2002 |
Congenital hypofibrinogenemia
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
In this study, we report the identification of a novel nonsense mutation (Arg134Xaa) in the FGG gene responsible for congenital afibrinogenemia in 10 patients from Lebanon.
|
15284111 |
2004 |
Afibrinogenemia
|
0.530 |
GeneticVariation
|
disease |
LHGDN |
Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in transfected cells.
|
15284111 |
2004 |
Vascular Diseases
|
0.010 |
Biomarker
|
group |
LHGDN |
Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease.
|
15217804 |
2004 |
Fibrinogen Deficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We have identified a novel heterozygous fibrinogen gamma chain mutation, gammaN345S (Fibrinogen Saint-Germain II), in a subject with hypofibrinogenemia.
|
16363237 |
2005 |
Dysfibrinogenemia, Congenital
|
0.610 |
GermlineCausalMutation
|
disease |
ORPHANET |
Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to gamma S378P mutation.
|
15632207 |
2005 |
Dysfibrinogenemia, Congenital
|
0.610 |
GeneticVariation
|
disease |
UNIPROT |
Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to gamma S378P mutation.
|
15632207 |
2005 |
Hypofibrinogenemia
|
0.190 |
GeneticVariation
|
disease |
BEFREE |
We have identified a novel heterozygous fibrinogen gamma chain mutation, gammaN345S (Fibrinogen Saint-Germain II), in a subject with hypofibrinogenemia.
|
16363237 |
2005 |
Fibrinogen Deficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A novel mutation in the FGG gene (G7590A) was found in all patients from the two families with hypofibrinogenemia.
|
16607083 |
2006 |
Liver Cirrhosis, Experimental
|
0.200 |
Biomarker
|
disease |
RGD |
Abnormal expression of Smurf2 during the process of rat liver fibrosis.
|
17054587 |
2006 |
Hypofibrinogenemia
|
0.190 |
GeneticVariation
|
disease |
BEFREE |
A novel mutation in the FGG gene (G7590A) was found in all patients from the two families with hypofibrinogenemia.
|
16607083 |
2006 |
Pneumonia
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Cell type-specific differential induction of the human gamma-fibrinogen promoter by interleukin-6.
|
16524883 |
2006 |
Congenital hypofibrinogenemia
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen gamma-chain gene as a novel mechanism for congenital afibrinogenaemia.
|
17854317 |
2007 |
Congenital hypofibrinogenemia
|
0.740 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations.
|
17295221 |
2007 |
Venous Thrombosis
|
0.110 |
GeneticVariation
|
phenotype |
LHGDN |
Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen gamma'/gammaA mRNA ratio.
|
17403086 |
2007 |
Arteriosclerosis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, fibrinogen FGG and FGA gene haplotypes are not associated with coronary events, coronary atherosclerosis or extracoronary atherosclerosis.
|
17264959 |
2007 |
Atherosclerosis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, fibrinogen FGG and FGA gene haplotypes are not associated with coronary events, coronary atherosclerosis or extracoronary atherosclerosis.
|
17264959 |
2007 |
Deep Vein Thrombosis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We propose that the 10034C>T change is the functional variation in FGG-H2 that is responsible for the reduction in the fibrinogen gamma'/total fibrinogen ratio and the increased DVT risk.
|
17403086 |
2007 |